Dextromethorphan
Opium Alkaloids and Derivatives
Sold as ROBITUSSIN DRY COUGH… · MULTI-ACTION ACTIFED DRY…
- Drug class
- Opium Alkaloids and Derivatives
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 10
- FDA reports (12 mo)
- 2,690
Overview
Dextromethorphan is an active pharmaceutical ingredient in the Opium Alkaloids and Derivatives group (R05DA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 8 | May 29, 2026 |
| US United States | FDA | 2 | May 13, 2026 |
GBUnited Kingdom· MHRA
8 products
Uses
Cough suppressant for the relief of acute non-productive (dry, tickly) cough associated with respiratory tract infection. For oral administration.
How to take
USUnited States· FDA
2 products
Uses
Use temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
How to take
Drug interactions
Known interactions involving Dextromethorphan. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 292. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL000140357 · revised November 14, 2025
- [2]FDA DailyMed · 028b025e-2dde-4b… · revised November 21, 2024 [PDF]
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.